PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma

The expansion of nanotechnology for drug delivery applications has raised questions regarding the safety of nanoparticles (NPs) due to their potential for interacting at molecular and cellular levels. Although polymeric NPs for drug delivery are formulated using FDA-approved polymers such as lactide...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhaidar, Rana, O’Neill, Sarah, Ramtoola, Zebunnissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767100/
https://www.ncbi.nlm.nih.gov/pubmed/33352749
http://dx.doi.org/10.3390/ijms21249716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767100/
https://www.ncbi.nlm.nih.gov/pubmed/33352749
http://dx.doi.org/10.3390/ijms21249716

Ejemplares similares